Vanguard Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Buy |
129,839
+14,753
| +13% | +$39.4K | ﹤0.01% | 3996 |
|
|
2025
Q1 | $924K | Sell |
115,086
-1
| -0% | -$8 | ﹤0.01% | 3735 |
|
|
2024
Q4 | $1.11M | Hold |
115,087
| – | – | ﹤0.01% | 3730 |
|
|
2024
Q3 | $2.14M | Hold |
115,087
| – | – | ﹤0.01% | 3538 |
|
|
2024
Q2 | $1.91M | Sell |
115,087
-11,976
| -9% | -$199K | ﹤0.01% | 3567 |
|
|
2024
Q1 | $2.21M | Sell |
127,063
-702
| -0.5% | -$12.2K | ﹤0.01% | 3560 |
|
|
2023
Q4 | $2M | Buy |
127,765
+8,133
| +7% | +$127K | ﹤0.01% | 3605 |
|
|
2023
Q3 | $5.92M | Buy |
119,632
+2,592
| +2% | +$128K | ﹤0.01% | 3176 |
|
|
2023
Q2 | $9.15M | Sell |
117,040
-12,213
| -9% | -$955K | ﹤0.01% | 2995 |
|
|
2023
Q1 | $11.7M | Buy |
129,253
+952
| +0.7% | +$86.3K | ﹤0.01% | 2853 |
|
|
2022
Q4 | $15.1M | Buy |
128,301
+1,727
| +1% | +$204K | ﹤0.01% | 2761 |
|
|
2022
Q3 | $23M | Buy |
126,574
+37,530
| +42% | +$6.81M | ﹤0.01% | 2568 |
|
|
2022
Q2 | $7.99M | Sell |
89,044
-27,404
| -24% | -$2.46M | ﹤0.01% | 3109 |
|
|
2022
Q1 | $18.1M | Sell |
116,448
-5,012
| -4% | -$778K | ﹤0.01% | 2829 |
|
|
2021
Q4 | $36.1M | Sell |
121,460
-55
| -0% | -$16.4K | ﹤0.01% | 2530 |
|
|
2021
Q3 | $70M | Buy |
121,515
+19,239
| +19% | +$11.1M | ﹤0.01% | 2174 |
|
|
2021
Q2 | $46.4M | Buy |
102,276
+7,256
| +8% | +$3.29M | ﹤0.01% | 2416 |
|
|
2021
Q1 | $51.1M | Buy |
95,020
+33,752
| +55% | +$18.2M | ﹤0.01% | 2304 |
|
|
2020
Q4 | $54.2M | Buy |
61,268
+2,327
| +4% | +$2.06M | ﹤0.01% | 2154 |
|
|
2020
Q3 | $37.3M | Buy |
+58,941
| New | +$37.3M | ﹤0.01% | 2160 |
|